![Søren Morgenthaler Echwald](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Søren Morgenthaler Echwald
Algemeen Directeur bij Anapa Biotech A/S
Profiel
Søren Morgenthaler Echwald is currently the Chief Executive Officer at Anapa Biotech A and a Director at Ranger Biotechnologies A.
He was previously the Vice President-Business Development at Exiqon A.
Actieve functies van Søren Morgenthaler Echwald
Bedrijven | Functie | Begin |
---|---|---|
Anapa Biotech A/S
![]() Anapa Biotech A/S Miscellaneous Commercial ServicesCommercial Services Anapa Biotech A/S provides molecular tools to enhance the performance of natural nucleic acids. Its technology is the proprietary Twisted Intercalating Nucleic Acid molecules. The company was founded by Gorm Lisby and Henrik Westh in 2002 and is headquartered in Hørsholm, Denmark. | Algemeen Directeur | - |
Ranger Biotechnologies A/S
![]() Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Søren Morgenthaler Echwald
Bedrijven | Functie | Einde |
---|---|---|
EXIQON A/S | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Exiqon A/S
![]() Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Exiqon A/S engages in the development of solutions for ribonucleic acid research and analysis through its Locked Nucleic Acid proprietary technology. Its products and services are used by researchers in academia, biotech, and pharmaceutical companies around the world to make discoveries about the correlation between gene activity and the development of disease. The company was founded by Mikael Ørum, Henrik Ørum and Troels Koch on November 1, 1995 and is headquartered in Copenhagen, Denmark. | Commercial Services |
Anapa Biotech A/S
![]() Anapa Biotech A/S Miscellaneous Commercial ServicesCommercial Services Anapa Biotech A/S provides molecular tools to enhance the performance of natural nucleic acids. Its technology is the proprietary Twisted Intercalating Nucleic Acid molecules. The company was founded by Gorm Lisby and Henrik Westh in 2002 and is headquartered in Hørsholm, Denmark. | Commercial Services |
Ranger Biotechnologies A/S
![]() Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Commercial Services |